JENCYCLA 0.35 MG
NORETHINDRONE : 0.35 MG · DIN 02441306 · LUPIN PHARMA CANADA LIMITED
Health Canada status: MARKETED
What is JENCYCLA?
JENCYCLA 0.35 MG contains NORETHINDRONE : 0.35 MG. It is listed in the Health Canada Drug Product Database under DIN 02441306, held by LUPIN PHARMA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 14-Aug-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is JENCYCLA used for?
JENCYCLA Tablets are indicated for conception control. JENCYCLA Tablets contain a low dosage of norethindrone without the addition of an estrogen agent. Progestin-only pills are often called "progestin-only pills" or the "mini-pill".
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02441306 |
|---|---|
| Brand name | JENCYCLA |
| Generic / active ingredient | NORETHINDRONE : 0.35 MG |
| Manufacturer | LUPIN PHARMA CANADA LIMITED |
| Strength | 0.35 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | G03AC01 NORETHISTERONE |
| AHFS class | 68:12.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 14-Aug-2018 |
| Original market date | 2015-09-14 00:00:00 |
How is it stored and handled?
Store between 15°C - 30°C. Leave contents in protective packaging until time of use.
How is it supplied?
1 x 28 GREEN tablets each containing 0.35 mg norethindrone; 3 x 28 GREEN tablets each containing 0.35 mg norethindrone
What can be used instead?
Other Canadian products sharing ATC code G03AC01 NORETHISTERONE. 3 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MAEVE | 0.35 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED | DIN 02458683 |
| MOVISSE | 0.35 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED | DIN 02410303 |
| MICRONOR TABLETS 28-DAY | 0.35 MG | TABLET | JANSSEN INC | CANCELLED POST MARKET | DIN 00037605 |
Who else supplies NORETHISTERONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. NORETHISTERONE appears in 14 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.